We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation

By HospiMedica International staff writers
Posted on 18 Dec 2023
Print article
Image: AI-powered algorithm could better assess people’s risk of common heart condition (Photo courtesy of 123RF)
Image: AI-powered algorithm could better assess people’s risk of common heart condition (Photo courtesy of 123RF)

Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib can lead to the formation of blood clots in the heart, which can then trigger strokes. Additionally, AFib is known to raise the likelihood of heart failure or even death. To mitigate these risks in patients diagnosed with AFib, healthcare professionals typically prescribe anticoagulants, which are medications that help prevent blood clots. They may also recommend various lifestyle and medical therapies. However, diagnosing AFib can be challenging, as many individuals experience only sporadic episodes of irregular heartbeat or exhibit minimal symptoms. Common symptoms of AFib include heart palpitations, lightheadedness, shortness of breath, and chest pain. In cases where these symptoms are present, cardiologists generally conduct a detailed electrocardiogram (ECG) in their office, using ten electrodes placed on the patient's body to record heart rhythms for about ten seconds. If no immediate irregularities are observed, ongoing monitoring at home is usually recommended for a duration of one to two weeks, employing a simpler, wearable ECG patch that features a single electrode. However, this method may not always detect AFib in those who experience very infrequent episodes.

At Scripps Research (La Jolla, CA, USA), scientists have developed a novel artificial intelligence (AI) model aimed at enhancing the screening process for AFib. This model is adept at identifying subtle variations in normal heart rhythms that indicate a risk for AFib, which conventional screening methods might miss. The research utilized data from nearly half a million individuals, each of whom had worn an ECG patch for two weeks to record their heart rhythms. The AI model analyzed this data, identifying patterns that differentiated individuals with AFib from those without. This new model shows promise in improving the detection of those at risk for AFib, thereby potentially averting serious complications such as stroke and heart failure.

Notably, the machine learning model was more accurate at predicting AFib risk even after the researchers integrated all known AFib risk factors into their own, manual models—including demographic data and ECG measures such as the variability between different heart beats. It remained effective in predicting AFib risk across different age groups, including both older individuals, who have a higher risk of AFib, and those under 55, who typically have a lower risk and are often not included in general AFib screenings. While this model is not designed to diagnose AFib directly, it represents a significant step towards creating a screening test for those at heightened risk for AFib or exhibiting symptoms. This could mean wearing an ECG patch for just one day to ascertain if extended testing is necessary. Alternatively, the model might analyze data from one- or two-week ECG recordings to identify patients who should undergo repeat testing, even if no AFib is detected during the initial timeframe. The research team is planning a prospective study and aims to refine their models further by integrating additional data sources, such as electronic medical records.

“With this new tool, we can better identify patients at high risk of AFib for further tests and interventions,” says senior author Giorgio Quer, PhD, director of artificial intelligence at Scripps Research Translational Institute and an assistant professor of digital medicine at Scripps Research. “Long term, this can help drive the right resources to the right people and potentially reduce the incidence of stroke and heart failure.”

Related Links:
Scripps Research

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
Digital Brain Electric Activity Mapping Unit

Print article


Critical Care

view channel
Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)

Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions

The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read more

Surgical Techniques

view channel
Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF)

Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy

According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.